Back to search

Aristotle University Of Thessaloniki (AUTH)

Η επίδραση της ηπατικής ισχαιμίας-επαναιμάτωσης στο καρδιακό σύστημα: πειραματική μελέτη των δεικτών και της πιθανής προστατευτικής δράσης της τρεπροστινίλης και της ισχαιμικής προετοιμασίας

Abstract

dc:description

Hepatic ischemia-reperfusion injury (HIRI) remains a major cause of postoperative liver dysfunction following extensive hepatectomies and liver transplantation. Due to its progressive and dynamic nature, hepatic ischemia-reperfusion can lead to multiple organ failure and worsened outcomes. Therefore, a deeper understanding of the pathophysiological mechanisms underlying hepatocellular injury is essential, along with an evaluation of systemic consequences. Further research is needed to identify protective techniques and pharmacological agents that address both local and systemic post-ischemic effects. Treprostinil, a relatively new synthetic analogue of prostacyclin, shows potential beneficial effects against hepatic ischemia-reperfusion injury. Ischemic preconditioning (IP) is a promising method with protective effects on hepatic ischemia-reperfusion syndrome, although the optimal protocol remains to be established. This study aimed to analyse HIRI biomarkers, their effects on the liver and heart, and the impact of treprostinil and ischemic preconditioning on these processes. Forty male Wistar Albino rats, aged 3 to 4 months, were randomly assigned to four groups of ten. All rats underwent a 3-hour surgical intervention, and were subsequently sacrificed. Hepatic ischemia was induced by clamping the hepatoduodenal ligament for 30 minutes, followed by reperfusion for 120 minutes. Rats received either treprostinil at a dose of 100 ng/kg/min for 24 hours or ischemic preconditioning prior to hepatic ischemia-reperfusion injury. The control group received no protective treatment, and one group underwent a sham operation. Liver and heart tissues were examined for histopathological changes. Serum levels of SGOT, SGPT, CPK, LDH, CRP, troponin I, IL-1β, TNF-α, endothelin-1, and protein carbonylation content were measured. Additionally, liver IL-1β and protein carbonylation levels were assessed. HIRI deteriorated hepatocellular function and exacerbated liver and myocardial damage in the control group (p < 0.001). HIRI triggered overexpression of IL-1β, TNF-α, endothelin-1, and protein carbonyl content, leading to oxidative stress. In rat serum and tissue samples, lower levels of troponin I (186.3 ± 253.7 vs. 3846.9 ± 2441.2 pg/mL, p < 0.001) were significantly correlated with reduced cellular necrosis and improved hepatocellular function (SGOT 616.3 ± 42.9 vs. 946.4 ± 59.1 U/L; SGPT 734.4 ± 226.9 vs. 1210.6 ± 234.4 U/L; LDH 1439.7 ± 339.9 vs. 5896.0 ± 592.2 U/L; p ≤ 0.001) in the treprostinil group compared to the HIRI group. Furthermore, our data showed that treprostinil administration led to better attenuation of oxidative stress and hepatocellular and myocardial damage compared to the ischemic preconditioning group. A statistically significant difference was observed in the levels of TNF-α (6.52 ± 0.72 vs. 8.43 ± 0.89 pg/mL, p < 0.001), IL-1β (89.56 ± 5.00 vs. 118.57 ± 8.72 pg/mL in serum, 128.88 ± 5.05 vs. 165.34 ± 10.68 pg/mL in tissue; both p < 0.001), endothelin-1 (4.48 ± 0.75 vs. 5.82 ± 0.27 pg/mL, p = 0.001) and tissue carbonyl content levels (4.17 ± 0.40 vs. 6.29 ± 0.67 nmol/mg, p < 0.001). However, no significant differences were observed in the levels of CPK and protein carbonyl concentration in serum (p > 0.05). Similar but less pronounced effects were noted in the ischemic preconditioning group. Both treprostinil and ischemic preconditioning demonstrated protective effects in hepatic and cardiac tissues. Treprostinil exhibited slightly superior cardioprotective efficacy, as evidenced by a statistically significant difference in troponin I levels (p < 0.001) and histopathological scoring of myocardial samples, while no differences were observed in the other parameters. This experimental model is well established, providing safe and well-documented results. However, additional clinical studies are necessary to confirm these findings, support the application of the drug in clinical practice, and obtain the required approval from the FDA. Nonetheless, our experimental results were positive: adequate anesthesia and analgesia were successfully achieved, and significant therapeutic effects of treprostinil and IP were observed in the study groups compared to the control group. The findings of our study support the conclusion that hepatic ischemia-reperfusion injury induces oxidative stress and promotes cytokine overexpression, leading to impaired liver function and exacerbated myocardial injury. To our knowledge, this is the first study to evaluate the protective effects of treprostinil and hepatic IP on myocardial damage in the context of HIRI. The protective effects of treprostinil may be attributed to its vasodilatory and anti-inflammatory mechanisms. Accordingly, the attenuation of oxidative stress and reduction of the inflammatory response represent possible hepatoprotective pathways of IP. These results suggest that treprostinil and IP may exert beneficial effects in protecting the liver and heart against damage induced by HIRI. Notably, compared with IP, treprostinil appeared to offer slightly superior cardioprotection. Further large-scale experimental and clinical studies are essential to validate the safety and therapeutic efficacy of treprostinil administration in liver transplantation and liver surgery before its application in clinical practice.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Mouratidou, Kristina
  • Μουρατίδου, Κριστίνα

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/60691

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Mouratidou, Kristina; Μουρατίδου, Κριστίνα. Η επίδραση της ηπατικής ισχαιμίας-επαναιμάτωσης στο καρδιακό σύστημα: πειραματική μελέτη των δεικτών και της πιθανής προστατευτικής δράσης της τρεπροστινίλης και της ισχαιμικής προετοιμασίας. Aristotle University Of Thessaloniki (AUTH), 2026. http://hdl.handle.net/10442/hedi/60691